Stock Screener App

Frei -

Installieren

3.1507

1.10% -0.0293

Myriad Genetics Inc (MYGN)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt MYGN? Forum Prognose Aktiensplit

Myriad Genetics Inc Aktie (MYGN) Neueste Nachrichten

Therapeutics Stocks Q2 Recap: Benchmarking Myriad Genetics (NASDAQ:MYGN) - Yahoo Finance

Myriad Genetics Inc. (MYGN) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com

BlackRock arm now owns more than a tenth of Myriad Genetics (NASDAQ: MYGN) - Stock Titan

Stocks making big moves yesterday: Myriad Genetics, Greenbrier, Tidewater, Strategy, and Charter - Yahoo Finance

Why Myriad Genetics (MYGN) Stock Is Down Today - Yahoo Finance

Myriad Genetics stock downgraded at Piper Sandler (MYGN:NASDAQ) - Seeking Alpha

Myriad Genetics Stock Gets Double-Downgrade as Profitability Concerns Grow - Barron's

Myriad Genetics shares fall 7.1% after Piper Sandler downgrade - Yahoo Finance

Why is Myriad Genetics stock tumbling today? By Investing.com - Investing.com South Africa

Why is Myriad Genetics stock tumbling today? - Investing.com

Piper Sandler cuts Myriad Genetics stock rating on profit concerns By Investing.com - Investing.com Nigeria

Piper Sandler Downgrades Myriad Genetics(MYGN.US) to Sell Rating, Cuts Target Price to $2 - Moomoo

Myriad Genetics Inc. (MYGN) Peer Comparison – Compare with Others - Value Research

Myriad Genetics to Present at 2026 Wells Fargo Healthcare Conference - GlobeNewswire

Myriad Genetics and Moderna Shares Plummet, What You Need To Know - Yahoo Finance

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect - ACCESS Newswire

Burning Rock and Myriad Announce Global Strategic Technology Lice - The National Law Review

MYGN INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Myriad Genetics Inc. - accessnewswire.com

MYGN Maintained by Stephens & Co. -- Price Target Lowered to $3. - GuruFocus

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Marquis Who's Who Honors Ben Wheeler for Expertise in Finance and Healthcare - 24-7 Press Release Newswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Myriad Genetics (MYGN): Glenview Capital and Larry Robbins report exit from stake - Stock Titan

Myriad Genetics (MYGN): Vestal Point Capital discloses 6.1% stake in 13G filing - Stock Titan

Myriad Genetics Faces Multiple Investor Investigations - stl.news

MYGN SHAREHOLDER ALERT: Myriad Genetics Inc. Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations - Business Wire

Dimensional Fund Advisors LP Reduces Stake in Myriad Genetics, Inc. $MYGN - MarketBeat

Myriad Genetics Inc at JPMorgan Healthcare Conference Transcript - GuruFocus

Assenagon Asset Management S.A. Reduces Holdings in Myriad Genetics, Inc. $MYGN - MarketBeat

3 Healthcare Stocks with Open Questions - Yahoo Finance

Price-Driven Insight from (MYGN) for Rule-Based Strategy - Stock Traders Daily

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, In - The National Law Review

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Reach Out - ACCESS Newswire

Myriad Genetics (MYGN) Securities Investigation NoticeLevi & Korsinsky - PR Newswire

Myriad Genetics And 2 Other Promising Penny Stocks For Your Watchlist - simplywall.st

Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Stockholders to Connect - accessnewswire.com

MYGN Investors Have Opportunity to Join Myriad Genetics, Inc. Fraud Investigation with SBS Law - FinancialContent

Myriad Genetics (NASDAQ:MYGN) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat

Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Myriad Genetics Inc (MYD.HA) stock price, news, quote and history - Yahoo Finance Australia

State Street Corporation (NYSE: STT) discloses 5.3% holding in Myriad Genetics - Stock Titan

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Through a Challenging Landscape with 69.36% Potential Upside - DirectorsTalk Interviews

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Myriad Genetics (MYGN) - globenewswire.com

Myriad Genetics (NASDAQ:MYGN) Lowered to Strong Sell Rating by Zacks Research - MarketBeat

MYRIAD GENETICS, INC. INVESTOR ALERT: Kirby McInerney LLP - GlobeNewswire

MYGN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Myriad Genetics (MYGN) - Business Wire

MYGN SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Myriad Genetics - Morningstar

Myriad Genetics, Inc. (MYGN) Investors Who Suffered Losses Are Encouraged to Contact Johnson Fistel - GlobeNewswire

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.34, Implies 87% Upside - TradingView

Myriad Genetics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Myriad Genetics (MYGN) - PR Newswire

MYGN Slides As Myriad Genetics Slashes 2026 Revenue Outlook - timothysykes.com

MYGN Stock Slides As Myriad Genetics Slashes 2026 Outlook - timothysykes.com

Myriad Genetics: Strong Oncology Demand, But Monetization Breaks Down (NASDAQ:MYGN) - Seeking Alpha

Myriad Genetics, Inc. Stock 12‑Month Price Target Cut to $5.75, Implies 7% Upside - TradingView

Myriad Genetics Stock Drops Sharply After Hours: What Investors Need to KnowMyriad Genetics (NASDAQ:MY - Benzinga

MYRIAD GENETICS ($MYGN) Releases Q2 2026 Earnings - Quiver Quantitative

Myriad: Q2 Earnings Snapshot - KVUE

MTD

$1,299.69

1.84%

LH

$322.57

0.68%

ILMN

$207.84

1.57%

WAT

$409.13

1.66%

A

$145.29

1.07%

IDXX

$521.28

0.15%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters